Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity

References

• World Health Organization, Malaria fact sheet, available at http://www.who.int/mediacentre/factsheets/fs094/en/ (accessed April 2016).
   Google Scholar
• World Health Organization, World Malaria Report 2015, available at http://www.who.int/malaria/publications/world-malaria-report-2015/en/ (accessed April 2016).
   Google Scholar
• M. Löffler, L.D. Fairbanks, E. Zameitat, A.M. Marinaki, and H.A. Simmonds, Pyrimidine pathways in health and disease, Trends Mol Med. 11 (2005), pp. 430–437.
   PubMed Web of Science ®Google Scholar
• M.A. Phillips and P.K. Rathod, Plasmodium falciparum dihydroorotate dehydrogenase: A promising target for novel anti-malarial chemotherapy, Infect. Disord. Drug Targets 10 (2010), pp. 226–239.
   PubMedGoogle Scholar
• V.K. Vyas and M. Ghate, Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors, Mini. Rev. Med. Chem. 11 (2011), pp. 1039–1055.
   PubMed Web of Science ®Google Scholar
• R. Gujjar, A. Marwaha, F. El Mazouni, J. White, K.L. White, S. Creason, D.M. Shackleford, J. Baldwin, W.N. Charman, F.S. Buckner, and S. Charman, Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice, J. Med. Chem. 52 (2009), pp. 1864–1872.
   PubMed Web of Science ®Google Scholar
• M.L. Booker, C.M. Bastos, M.L. Kramer, R.H. Jr Barker, R. Skerlj, A.B. Sidhu, X. Deng, C. Celatka, J.F. Cortese, J.E. Guerrero Bravo, K.N. Crespo Llado, A.E. Serrano, I. Angulo-Barturen, M.B. Jiménez-Díaz, S. Viera, H. Garuti, S. Wittlin, P. Papastogiannidis, J.W. Lin, C.J. Janse, S.M. Khan, M. Duraisingh, B. Coleman, E.J. Goldsmith, M.A. Phillips, B. Munoz, D.F. Wirth, J.D. Klinger, R. Wiegand, and E. Sybertz, Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model, J. Biol. Chem. 285 (2010), pp. 33054–33064.
   PubMed Web of Science ®Google Scholar
• J.M. Coteron, M. Marco, J. Esquivias, X. Deng, K.L. White, J. White, M. Koltun, F. El Mazouni, S. Kokkonda, K. Katneni, and R. Bhamidipati, Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential, J. Med. Chem. 54 (2011), pp. 5540–5561.
   PubMed Web of Science ®Google Scholar
• M.A. Phillips, J. Lotharius, K. Marsh, J. White, A. Dayan, K.L. White, J.W. Njoroge, F. Mazouni, Y. Lao, S. Kokkonda, D.R. Tomchick, X. Deng, T. Laird, S.N. Bhatia, S. March, C.L. Ng, D.A. Fidock, S. Wittlin, M. Lafuente-Monasterio, F.J. Benito, L.M. Alonso, M.S. Martinez, M.B. Jimenez-Diaz, S.F. Bazaga, I. Angulo-Barturen, J.N. Haselden, J. Louttit, Y. Cui, A. Sridhar, A.M. Zeeman, C. Kocken, R. Sauerwein, K. Dechering, V.M. Avery, S. Duffy, M. Delves, R. Sinden, A. Ruecker, K.S. Wickham, R. Rochford, J. Gahagen, L. Iyer, E. Riccio, and J. Mirsalis, Bathhurst, T. Rueckle, X. Ding, B. Campo, D. Leroy, M.J. Rogers, P.K. Rathod, J.N. Burrows, and S.A. Charman, A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria, Sci. Transl. Med. 7 (2015), p. 296111.
   Web of Science ®Google Scholar
• World Health Organization, Antimalarial drug resistance, available at http://www.who.int/malaria/areas/drug_resistance/overview/en/ (accessed May 2016).
   Google Scholar
• I.J. Frame, R. Deniskin, A. Arora, and M.H. Akabas, Purine import into malaria parasites as a target for antimalarial drug development, Ann. N. Y. Acad. Sci. 1342 (2015), pp. 19–28.
   PubMed Web of Science ®Google Scholar
• M.B. Cassera, Y. Zhang, K.Z. Hazleton, and V.L. Schramm, Purine and pyrimidine pathways as targets in Plasmodium falciparum, Curr. Top. Med. Chem. 11 (2011), pp. 2103–2115.
   PubMed Web of Science ®Google Scholar
• Y. Yuthavong, B. Tarnchompoo, T. Vilaivan, P. Chitnumsub, S. Kamchonwongpaisan, S.A. Charman, D.N. McLennan, K.L. White, L. Vivas, E. Bongard, C. Thongphanchang, S. Taweechai, J. Vanichtanankul, R. Rattanajak, U. Arwon, P. Fantauzzi, J. Yuvaniyama, W.N. Charman, and D. Matthews, Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target, Proc. Natl. Acad. Sci. U. S. A. 42 (2012), pp. 16823–16828.
   Web of Science ®Google Scholar
• V.G. Ugale and S.B. Bari, Identification of potential Gly/NMDA receptor antagonists by cheminformatics approach: A combination of pharmacophore modelling, virtual screening and molecular docking studies, SAR QSAR Environ. Res. 27 (2016), pp. 125–145.
   PubMed Web of Science ®Google Scholar
• A. Wadood and Z.U. Ulhaq, In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase, J. Mol. Graph. Model. 40 (2013), pp. 40–47.
   PubMed Web of Science ®Google Scholar
• M.A. Phillips, R. Gujjar, N.A. Malmquist, J. White, F.E. Mazouni, J. Baldwin, and P.K. Rathod, Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum, J. Med. Chem. 51 (2008), pp. 3649–3653.
   PubMed Web of Science ®Google Scholar
• D. Xiaoy, S. Kokkonda, F.E. Mazouni, J. White, J.N. Burrows, W. Kaminsky, S.A. Charman, D. Matthews, P.K. Rathod, and M.A. Phillips, Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors, J. Med. Chem. 57 (2014), pp. 5381–5394.
   PubMed Web of Science ®Google Scholar
• M. Davies, T. Heikkila, A.G. McConkey, C.W. Fishwick, M.R. Parsons, and A.P. Johnson, Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases, J. Med. Chem. 52 (2009), pp. 2683–2693.
   PubMed Web of Science ®Google Scholar
• L.R. McLean, Y. Zhang, W. Degnen, J. Peppard, D. Cabel, C.T. Zou, J.T. Say, A. Subramaniam, R.J. Vaz, and Y. Li, Discovery of novel inhibitors for DHODH via virtual screening and X-ray crystallographic structures, Bioorg. Med. Chem. Lett. 20 (2010), pp. 1981–1984.
   PubMed Web of Science ®Google Scholar
• T. Heikkilä, S. Thirumalairajan, M. Davies, M.R. Parsons, A.G. McConkey, C.W. Fishwick, and A.P. Johnson, The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase, Bioorg. Med. Chem. Lett. 16 (2006), pp. 88–92.
   PubMed Web of Science ®Google Scholar
• R.T. Skerlj, C.M. Bastos, M.L. Booker, M.L. Kramer, R.H. Barker, C.A. Celatka, T.J. O’Shea, B. Munoz, A.B. Sidhu, J.F. Cortese, S. Wittlin, P. Papastogiannidis, I. Angulo-Barturen, M.B. Jimenez-Diaz, and E. Sybertz, Optimization of potent inhibitors of P. falciparum dihydroorotate dehydrogenase for the treatment of malaria, ACS Med. Chem. Lett. 2 (2011), pp. 708–713.
   PubMed Web of Science ®Google Scholar
• A.N. Boa, S.P. Canavan, P.R. Hirst, C. Ramsey, A.M. Stead, and G.A. McConkey, Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase, Bioorg. Med. Chem. 13 (2005), pp. 1945–1967.
   PubMed Web of Science ®Google Scholar
• Tripos Associates, SYBYL X Molecular Modeling Software, Version 1.2 (2011), St. Louis, MO, available at http://www.tripos.com.
   Google Scholar
• J. Gasteiger and M. Marsili, Iterative partial equalization of orbital electronegativity – a rapid access to atomic charges, Tetrahedron 36 (1980), pp. 3219–3228.
   Web of Science ®Google Scholar
• M. Clark, R.D. Cramer III, and N.V. Opdenbosch, Validation of the general purpose Tripos 5.2 forcefield, J. Comput. Chem. 10 (1989), pp. 982–1012.
   Web of Science ®Google Scholar
• P. Yang, K.Z. Myint, Q. Tong, R. Feng, H. Cao, A.A. Almehizia, M.H. Alqarni, L. Wang, P. Bartlow, Y. Gao, J. Gertsch, J. Teramachi, N. Kurihara, G.D. Roodman, T. Cheng, and X.Q. Xie, Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB2 receptor inverse agonists and osteoclast inhibitors, J. Med. Chem. 55 (2012), pp. 9973–9987.
   PubMed Web of Science ®Google Scholar
• V.K. Vyas, A. Goel, and M. Ghate, Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKBβ) inhibitors, J Mol. Graph. Model. 42 (2013), pp. 17–25.
   PubMed Web of Science ®Google Scholar
• T. Fawcett, An introduction to ROC analysis, Pattern Recogn. Lett. 27 (2006), pp. 861–874.
   Web of Science ®Google Scholar
• N. Huang, B.K. Shoichet, and J.J. Irwin, Benchmarking sets for molecular docking, J. Med. Chem. 49 (2006), pp. 6789–6801.
   PubMed Web of Science ®Google Scholar
• O.F. Güner, Metric for analysing hit lists and pharmacophores, in Pharmacophore Perception, Development, and Use in Drug Design, O.F. Güner, ed., International University Line, La Jolla, CA, 2000, pp. 191–211.
   Google Scholar
• O.F. Güner, Strategies for database mining and pharmacophore development, in Pharmacophore Perception, Development, and Use in Drug Design, O.F. Güner, ed., International University Line, La Jolla, CA, 2000, pp. 213–236.
   Google Scholar
• I. Muegge, Selection criteria for drug-like compounds, Med. Res. Rev. 23 (2003), pp. 302–321.
   PubMed Web of Science ®Google Scholar
• A.N. Jain, Scoring noncovalent protein-ligand interactions: A continuous differentiable function tuned to compute binding affinities, J. Comput-Aided Mol. Des. 10 (1996), pp. 427–440.
   PubMed Web of Science ®Google Scholar
• X. Deng, R. Gujjar, F.E. Mazouni, W. Kaminsky, N.A. Malmquist, E.J. Goldsmith, P.K. Rathod, and M.A. Phillips, Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds, J. Biol Chem. 284 (2009), pp. 26999–27009.
   PubMed Web of Science ®Google Scholar
• http://www.organic-chemistry.org/prog/peo, (accessed October 2015).
   Google Scholar
• https://preadmet.bmdrc.kr/adme/ (accessed March 2016).
   Google Scholar
• A.B. Isah, Y.K. Ibrahim, and E.O. Iwalewa, Evaluation of the antimalarial properties and standardization of tablets of Azadirachta indica (Meliaceae) in mice, Phytother. Res. 17 (2003), pp. 807–810.
   PubMed Web of Science ®Google Scholar